Skip to main content
Clinical Trials/NCT03573765
NCT03573765
Completed
Not Applicable

The Role of Patient Factors, Surgical Factors and Hospital Factors Upon Patient Outcomes and NHS Costs in the Treatment of Upper Limb Musculoskeletal Conditions: Spatial and Iongitudinal Analysis of Routine Data

University of Oxford0 sites8,308,821 target enrollmentApril 6, 1998

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
University of Oxford
Enrollment
8308821
Primary Endpoint
Revision and reoperation
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Surgery is a common treatment type for damaged joints, tendons and nerves in the upper limb where conservative measures are inappropriate or have failed. These conditions are common and result in significant levels of pain and functional disability. The investigators are conducting a broad ranging study of variation in the provision of surgical treatment and factors affecting outcomes after surgical treatment of upper limb conditions. This will be a population-based study of all patients undergoing surgical treatment funded by the National Health Service (NHS) of England over a nineteen-year period. This study will help to understand the factors associated with a poor outcome following surgery, which can be shared with patients considering treatment options. The investigators will also document current and future health service burden associated with commonly performed surgical procedures including complications and repeat operations.

Detailed Description

The investigators will conduct time series analyses, geospatial mapping and risk-factor association studies for both access to and outcomes of surgical treatments of the upper limbs. A large cohort of pseudonymised records will be extracted from the NHS Hospital Episode Statistics Admitted Patient Care database. Suitable patients will be identified based on a match to a specified list of International Classification of Diseases (ICD-10) and Office for Population Censuses and Surveys (OPCS-4) codes. Dates and cause of death will be linked from the Office for National Statistics (ONS) by NHS Digital. Separate analyses will be conducted for different intervention types with detailed outcomes reporting for high volume procedures. Adults will be defined as those aged 18 years or older at the time of surgery. Children will be defined as those aged less than 18 years at surgery and only included in a limited number of analyses where relevant (e.g. trigger digit). Key analyses: 1. Baseline demographics by procedure type 2. Procedure volume incidence trends * Time series analysis * Adjusted to standard population distributions * Geographical mapping including adjustment for sociodemographic indices including indices of deprivation 3. Revision, reoperation and mortality rates: * Estimation by Kaplan Meier and actuarial life table methods * Life time risk calculated by the cumulative probability method * Cox regression adjusted for comorbidities and demographic, social and geographic factors 4. Complications, length of stay, costs: * Logistic and linear regression models for binary and continuous outcomes respectively * Adjusted for comorbidities and demographic, social and geographic factors Where appropriate, the impact of replacing missing data will be explored with use of multiple imputation. All suitable patients will be entered into analyses to maximise statistical efficiency.

Registry
clinicaltrials.gov
Start Date
April 6, 1998
End Date
April 5, 2017
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Condition affecting one of:
  • All patients treated with surgery for any of the following:
  • Osteoarthritis
  • Inflammatory arthritis
  • Any other cause of arthropathy
  • Tendon tears
  • Peripheral neuropathy
  • Fractures and/or dislocations
  • Instability
  • Any arthroplasty surgery using a prosthesis

Exclusion Criteria

  • Patients registering a "type 2 opt out" - withholding NHS data from research use.

Outcomes

Primary Outcomes

Revision and reoperation

Time Frame: 1998-2017

Estimated at annual increments and standardised lifetime risk

Treatment volume: time series

Time Frame: 1998-2017

Crude and adjusted for population by age/sex

Treatment volume: geospatial patterns

Time Frame: 1998-2017

Mapped according to residence and NHS organisation boundaries

Secondary Outcomes

  • Complications(30, 45, 60, 90 days post surgery + 1 year and last recorded follow-up/censoring.)
  • Readmission to hospital(up to 30 days following surgery)
  • Healthcare related costs(up to 52 weeks from date of surgery)
  • Length of stay post surgery(up to 52 weeks from date of surgery)

Similar Trials